Clinical trials · Minnesota
Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 clinical trials in Minnesota
We’re tracking 6 recruiting stage iii oropharyngeal (p16-negative) carcinoma ajcc v8 studies with a site in Minnesota — including Phase 2 studies, each written for real people, not researchers.
Recruiting studies in Minnesota
- NCT05136196RecruitingPhase 2
Cabozantinib plus nivolumab for advanced melanoma or head-neck cancer
This trial tests whether combining two immunotherapy medicines—cabozantinib and nivolumab—can shrink advanced melanoma or certain head-and-neck squamous cell cancers. It is mainly for people whose cancer has grown after prior PD-1 treatment.
Bemidji, MinnesotaAges 18 years+ - NCT05541016RecruitingPhase 2
Personalized lower-dose radiation for HPV-related throat cancer
This Phase 2 study tests whether giving a less intense (de-escalated) radiation plan can work for certain people with HPV-related oropharyngeal throat cancer. It uses HPV blood testing and scans to help guide treatment, aiming to keep cancer control while reducing treatment side effects.
Rochester, MinnesotaAges 18 years+ - NCT06356272Recruiting
Oropharynx cancer biomarker study
This study looks at certain markers (called p16 and HPV) in tumor samples to better understand oropharynx cancer. It may help doctors learn more about the disease and guide future treatments.
Rochester, MinnesotaAges 18 years+ - NCT06532279RecruitingPhase 2
Testing BMX-001 with chemoradiation for head and neck cancer
This trial tests whether adding BMX-001 (a drug that may protect healthy tissues) to standard chemoradiation can reduce side effects and improve outcomes for people with head and neck cancer. It's a randomized study, so you would have a 50/50 chance of getting BMX-001 or a placebo.
Duluth, MinnesotaAges 18 years+ - NCT06997068RecruitingPhase 2
Drug combination for returning head and neck cancer
This trial tests a combination of three drugs—methotrexate, erlotinib, and celecoxib—for people whose head and neck cancer has come back or spread. It is designed for patients in the rural Midwest who have already had or chosen not to have standard first treatment.
Rochester, MinnesotaAges 18 years+ - NCT02734537RecruitingPhase 2
Radiation with or without cisplatin after head and neck surgery
This trial studies whether adding cisplatin (a chemotherapy medicine) to radiation therapy helps people with stage III–IVA squamous cell cancer of the head and neck after they’ve had surgery. It’s meant to lower the risk of the cancer coming back.
Aitkin, MinnesotaAges 18 years+
Where these studies are running in Minnesota
Institutions with a site for the recruiting stage iii oropharyngeal (p16-negative) carcinoma ajcc v8 studies listed above.
- Mayo Clinic · 5 studies
- Abbott-Northwestern Hospital · 2 studies
- Essentia Health - Deer River Clinic · 2 studies
- Essentia Health - Fosston · 2 studies
- Essentia Health - Park Rapids · 2 studies
- Essentia Health Cancer Center · 2 studies
- Essentia Health Hibbing Clinic · 2 studies
- Essentia Health Saint Joseph's Medical Center · 2 studies
What taking part in a stage iii oropharyngeal (p16-negative) carcinoma ajcc v8 study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 trials in other states
Common questions
- Are there stage iii oropharyngeal (p16-negative) carcinoma ajcc v8 clinical trials in Minnesota?
- Yes. We're currently tracking 6 recruiting stage iii oropharyngeal (p16-negative) carcinoma ajcc v8 studies with a site in Minnesota, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a stage iii oropharyngeal (p16-negative) carcinoma ajcc v8 study in Minnesota?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Minnesota to take part?
- Not necessarily. These studies have a site in Minnesota, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a stage iii oropharyngeal (p16-negative) carcinoma ajcc v8 trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New stage iii oropharyngeal (p16-negative) carcinoma ajcc v8 studies open in Minnesota regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.